Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 7, Issue 2, pp. 421-428
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 21, 2000
- Revision received November 9, 2000
- Accepted November 9, 2000
- Published first February 1, 2001.
Copyright & Usage
© 2001
Author Information
- Demetrius M. Kokkinakis2,
- Dora B. Bocangel,
- S. Clifford Schold,
- Robert C. Moschel, and
- Anthony E. Pegg
- Department of Neurosurgery, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235-8855 [D. M. K.]; University of Texas Medical Branch, Sealy Center for Molecular Science, Galveston, Texas 77555 [D. B. B.]; National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 [R. C. M.]; Departments of Cellular and Molecular Physiology and Pharmacology, Pennsylvania State University, College of Medicine, The Milton Hershey Medical Center, Hershey, Pennsylvania 17033 [A. E. P.]; and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213 [S. C. S.]
February 2001
Volume 7, Issue 2
Volume 7, Issue 2
Thresholds of O6-Alkylguanine-DNA Alkyltransferase which Confer Significant Resistance of Human Glial Tumor Xenografts to Treatment with 1,3-Bis(2-chloroethyl)-1-nitrosourea or Temozolomide
Jump to section
Advertisement